nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Progesterone—uterine cancer	0.153	0.222	CbGbCtD
Ticagrelor—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.138	0.201	CbGbCtD
Ticagrelor—ABCB1—Dactinomycin—uterine cancer	0.121	0.176	CbGbCtD
Ticagrelor—CYP3A4—Progesterone—uterine cancer	0.0917	0.133	CbGbCtD
Ticagrelor—ABCB1—Etoposide—uterine cancer	0.0685	0.0994	CbGbCtD
Ticagrelor—ABCB1—Doxorubicin—uterine cancer	0.0467	0.0678	CbGbCtD
Ticagrelor—CYP3A4—Etoposide—uterine cancer	0.041	0.0596	CbGbCtD
Ticagrelor—CYP3A4—Doxorubicin—uterine cancer	0.028	0.0406	CbGbCtD
Ticagrelor—P2RY12—artery—uterine cancer	0.0161	0.508	CbGeAlD
Ticagrelor—P2RY12—epithelium—uterine cancer	0.00611	0.193	CbGeAlD
Ticagrelor—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00449	CcSEcCtD
Ticagrelor—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00446	CcSEcCtD
Ticagrelor—Vertigo—Progesterone—uterine cancer	0.00124	0.00443	CcSEcCtD
Ticagrelor—Syncope—Progesterone—uterine cancer	0.00124	0.00442	CcSEcCtD
Ticagrelor—Vaginal haemorrhage—Epirubicin—uterine cancer	0.00122	0.00437	CcSEcCtD
Ticagrelor—Haemoptysis—Epirubicin—uterine cancer	0.00122	0.00437	CcSEcCtD
Ticagrelor—Loss of consciousness—Progesterone—uterine cancer	0.00121	0.00433	CcSEcCtD
Ticagrelor—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00432	CcSEcCtD
Ticagrelor—Haematemesis—Doxorubicin—uterine cancer	0.0012	0.0043	CcSEcCtD
Ticagrelor—Cough—Progesterone—uterine cancer	0.0012	0.0043	CcSEcCtD
Ticagrelor—Cardiac failure—Etoposide—uterine cancer	0.0012	0.00429	CcSEcCtD
Ticagrelor—Hypertension—Progesterone—uterine cancer	0.00119	0.00425	CcSEcCtD
Ticagrelor—Lung disorder—Doxorubicin—uterine cancer	0.00118	0.00423	CcSEcCtD
Ticagrelor—Chest pain—Progesterone—uterine cancer	0.00117	0.00419	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00117	0.00417	CcSEcCtD
Ticagrelor—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00408	CcSEcCtD
Ticagrelor—Confusional state—Progesterone—uterine cancer	0.00113	0.00405	CcSEcCtD
Ticagrelor—Vaginal haemorrhage—Doxorubicin—uterine cancer	0.00113	0.00404	CcSEcCtD
Ticagrelor—Haemoptysis—Doxorubicin—uterine cancer	0.00113	0.00404	CcSEcCtD
Ticagrelor—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00401	CcSEcCtD
Ticagrelor—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.004	CcSEcCtD
Ticagrelor—Shock—Progesterone—uterine cancer	0.00111	0.00396	CcSEcCtD
Ticagrelor—Nervous system disorder—Progesterone—uterine cancer	0.0011	0.00394	CcSEcCtD
Ticagrelor—Petechiae—Epirubicin—uterine cancer	0.0011	0.00393	CcSEcCtD
Ticagrelor—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00392	CcSEcCtD
Ticagrelor—Skin disorder—Progesterone—uterine cancer	0.00109	0.00391	CcSEcCtD
Ticagrelor—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.0038	CcSEcCtD
Ticagrelor—Neoplasm malignant—Epirubicin—uterine cancer	0.00106	0.00379	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00378	CcSEcCtD
Ticagrelor—Hypotension—Progesterone—uterine cancer	0.00105	0.00376	CcSEcCtD
Ticagrelor—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00367	CcSEcCtD
Ticagrelor—Petechiae—Doxorubicin—uterine cancer	0.00102	0.00364	CcSEcCtD
Ticagrelor—Paraesthesia—Progesterone—uterine cancer	0.00101	0.00361	CcSEcCtD
Ticagrelor—Dyspnoea—Progesterone—uterine cancer	0.001	0.00359	CcSEcCtD
Ticagrelor—Shock—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00359	CcSEcCtD
Ticagrelor—Rectal haemorrhage—Epirubicin—uterine cancer	0.001	0.00358	CcSEcCtD
Ticagrelor—Bone disorder—Epirubicin—uterine cancer	0.001	0.00358	CcSEcCtD
Ticagrelor—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00357	CcSEcCtD
Ticagrelor—Dyspepsia—Progesterone—uterine cancer	0.000991	0.00354	CcSEcCtD
Ticagrelor—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000991	0.00354	CcSEcCtD
Ticagrelor—CYP3A4—renal system—uterine cancer	0.000984	0.0311	CbGeAlD
Ticagrelor—Oliguria—Epirubicin—uterine cancer	0.000981	0.00351	CcSEcCtD
Ticagrelor—Neoplasm malignant—Doxorubicin—uterine cancer	0.00098	0.0035	CcSEcCtD
Ticagrelor—Hyperuricaemia—Epirubicin—uterine cancer	0.000975	0.00348	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Progesterone—uterine cancer	0.000972	0.00347	CcSEcCtD
Ticagrelor—Fatigue—Progesterone—uterine cancer	0.00097	0.00347	CcSEcCtD
Ticagrelor—Constipation—Progesterone—uterine cancer	0.000962	0.00344	CcSEcCtD
Ticagrelor—ABCB1—myometrium—uterine cancer	0.000957	0.0302	CbGeAlD
Ticagrelor—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000953	0.00341	CcSEcCtD
Ticagrelor—Feeling abnormal—Progesterone—uterine cancer	0.000927	0.00331	CcSEcCtD
Ticagrelor—Rectal haemorrhage—Doxorubicin—uterine cancer	0.000927	0.00331	CcSEcCtD
Ticagrelor—Bone disorder—Doxorubicin—uterine cancer	0.000927	0.00331	CcSEcCtD
Ticagrelor—Blood uric acid increased—Epirubicin—uterine cancer	0.000921	0.00329	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Progesterone—uterine cancer	0.00092	0.00329	CcSEcCtD
Ticagrelor—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000916	0.00327	CcSEcCtD
Ticagrelor—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000909	0.00325	CcSEcCtD
Ticagrelor—Oliguria—Doxorubicin—uterine cancer	0.000908	0.00325	CcSEcCtD
Ticagrelor—Hyperuricaemia—Doxorubicin—uterine cancer	0.000902	0.00322	CcSEcCtD
Ticagrelor—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000898	0.00321	CcSEcCtD
Ticagrelor—Body temperature increased—Progesterone—uterine cancer	0.00089	0.00318	CcSEcCtD
Ticagrelor—Abdominal pain—Progesterone—uterine cancer	0.00089	0.00318	CcSEcCtD
Ticagrelor—Melaena—Epirubicin—uterine cancer	0.000883	0.00316	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00088	0.00315	CcSEcCtD
Ticagrelor—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000879	0.00314	CcSEcCtD
Ticagrelor—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000872	0.00312	CcSEcCtD
Ticagrelor—Blood uric acid increased—Doxorubicin—uterine cancer	0.000852	0.00305	CcSEcCtD
Ticagrelor—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00084	0.003	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000834	0.00298	CcSEcCtD
Ticagrelor—Hypersensitivity—Progesterone—uterine cancer	0.000829	0.00296	CcSEcCtD
Ticagrelor—Ecchymosis—Epirubicin—uterine cancer	0.000818	0.00292	CcSEcCtD
Ticagrelor—Melaena—Doxorubicin—uterine cancer	0.000817	0.00292	CcSEcCtD
Ticagrelor—Asthenia—Progesterone—uterine cancer	0.000807	0.00289	CcSEcCtD
Ticagrelor—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000806	0.00288	CcSEcCtD
Ticagrelor—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000806	0.00288	CcSEcCtD
Ticagrelor—Urinary tract disorder—Etoposide—uterine cancer	0.0008	0.00286	CcSEcCtD
Ticagrelor—Pruritus—Progesterone—uterine cancer	0.000796	0.00285	CcSEcCtD
Ticagrelor—Urethral disorder—Etoposide—uterine cancer	0.000794	0.00284	CcSEcCtD
Ticagrelor—CYP3A4—female reproductive system—uterine cancer	0.000788	0.0249	CbGeAlD
Ticagrelor—Diarrhoea—Progesterone—uterine cancer	0.00077	0.00275	CcSEcCtD
Ticagrelor—Eye disorder—Etoposide—uterine cancer	0.000757	0.00271	CcSEcCtD
Ticagrelor—Ecchymosis—Doxorubicin—uterine cancer	0.000757	0.0027	CcSEcCtD
Ticagrelor—Cardiac disorder—Etoposide—uterine cancer	0.000752	0.00269	CcSEcCtD
Ticagrelor—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000751	0.00268	CcSEcCtD
Ticagrelor—ABCB1—epithelium—uterine cancer	0.000751	0.0237	CbGeAlD
Ticagrelor—ABCB1—uterine cervix—uterine cancer	0.000745	0.0235	CbGeAlD
Ticagrelor—Dizziness—Progesterone—uterine cancer	0.000744	0.00266	CcSEcCtD
Ticagrelor—Angiopathy—Etoposide—uterine cancer	0.000735	0.00263	CcSEcCtD
Ticagrelor—Immune system disorder—Etoposide—uterine cancer	0.000732	0.00262	CcSEcCtD
Ticagrelor—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000732	0.00261	CcSEcCtD
Ticagrelor—Mediastinal disorder—Etoposide—uterine cancer	0.00073	0.00261	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Epirubicin—uterine cancer	0.000724	0.00259	CcSEcCtD
Ticagrelor—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000721	0.00258	CcSEcCtD
Ticagrelor—Vomiting—Progesterone—uterine cancer	0.000716	0.00256	CcSEcCtD
Ticagrelor—Renal failure acute—Epirubicin—uterine cancer	0.000711	0.00254	CcSEcCtD
Ticagrelor—ABCB1—decidua—uterine cancer	0.00071	0.0224	CbGeAlD
Ticagrelor—Rash—Progesterone—uterine cancer	0.00071	0.00254	CcSEcCtD
Ticagrelor—Dermatitis—Progesterone—uterine cancer	0.000709	0.00253	CcSEcCtD
Ticagrelor—Headache—Progesterone—uterine cancer	0.000705	0.00252	CcSEcCtD
Ticagrelor—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000698	0.00249	CcSEcCtD
Ticagrelor—ABCB1—renal system—uterine cancer	0.000697	0.022	CbGeAlD
Ticagrelor—Fatigue—Dactinomycin—uterine cancer	0.000686	0.00245	CcSEcCtD
Ticagrelor—Back pain—Etoposide—uterine cancer	0.000682	0.00244	CcSEcCtD
Ticagrelor—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000674	0.00241	CcSEcCtD
Ticagrelor—ABCB1—endometrium—uterine cancer	0.000674	0.0213	CbGeAlD
Ticagrelor—Cardiac failure—Epirubicin—uterine cancer	0.000673	0.0024	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00067	0.00239	CcSEcCtD
Ticagrelor—Nausea—Progesterone—uterine cancer	0.000668	0.00239	CcSEcCtD
Ticagrelor—Renal failure acute—Doxorubicin—uterine cancer	0.000658	0.00235	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000657	0.00235	CcSEcCtD
Ticagrelor—Feeling abnormal—Dactinomycin—uterine cancer	0.000655	0.00234	CcSEcCtD
Ticagrelor—ABCB1—mammalian vulva—uterine cancer	0.000652	0.0206	CbGeAlD
Ticagrelor—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00065	0.00232	CcSEcCtD
Ticagrelor—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000648	0.00232	CcSEcCtD
Ticagrelor—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000643	0.0023	CcSEcCtD
Ticagrelor—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000642	0.0023	CcSEcCtD
Ticagrelor—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000639	0.00228	CcSEcCtD
Ticagrelor—Vertigo—Etoposide—uterine cancer	0.000634	0.00226	CcSEcCtD
Ticagrelor—Abdominal pain—Dactinomycin—uterine cancer	0.000629	0.00225	CcSEcCtD
Ticagrelor—Body temperature increased—Dactinomycin—uterine cancer	0.000629	0.00225	CcSEcCtD
Ticagrelor—Cardiac failure—Doxorubicin—uterine cancer	0.000622	0.00222	CcSEcCtD
Ticagrelor—ABCB1—uterus—uterine cancer	0.000621	0.0196	CbGeAlD
Ticagrelor—Loss of consciousness—Etoposide—uterine cancer	0.00062	0.00222	CcSEcCtD
Ticagrelor—Cough—Etoposide—uterine cancer	0.000616	0.0022	CcSEcCtD
Ticagrelor—Blood creatinine increased—Epirubicin—uterine cancer	0.000615	0.0022	CcSEcCtD
Ticagrelor—Hypertension—Etoposide—uterine cancer	0.000609	0.00218	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000608	0.00217	CcSEcCtD
Ticagrelor—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000606	0.00216	CcSEcCtD
Ticagrelor—Chest pain—Etoposide—uterine cancer	0.000601	0.00215	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000596	0.00213	CcSEcCtD
Ticagrelor—Breast disorder—Epirubicin—uterine cancer	0.000593	0.00212	CcSEcCtD
Ticagrelor—Hypersensitivity—Dactinomycin—uterine cancer	0.000586	0.00209	CcSEcCtD
Ticagrelor—Gastritis—Epirubicin—uterine cancer	0.000581	0.00208	CcSEcCtD
Ticagrelor—Confusional state—Etoposide—uterine cancer	0.00058	0.00207	CcSEcCtD
Ticagrelor—Asthenia—Dactinomycin—uterine cancer	0.000571	0.00204	CcSEcCtD
Ticagrelor—Blood creatinine increased—Doxorubicin—uterine cancer	0.000569	0.00203	CcSEcCtD
Ticagrelor—Skin disorder—Etoposide—uterine cancer	0.000559	0.002	CcSEcCtD
Ticagrelor—ABCB1—female reproductive system—uterine cancer	0.000558	0.0176	CbGeAlD
Ticagrelor—Breast disorder—Doxorubicin—uterine cancer	0.000549	0.00196	CcSEcCtD
Ticagrelor—Diarrhoea—Dactinomycin—uterine cancer	0.000544	0.00194	CcSEcCtD
Ticagrelor—Hypotension—Etoposide—uterine cancer	0.000538	0.00192	CcSEcCtD
Ticagrelor—Gastritis—Doxorubicin—uterine cancer	0.000538	0.00192	CcSEcCtD
Ticagrelor—Paraesthesia—Etoposide—uterine cancer	0.000517	0.00185	CcSEcCtD
Ticagrelor—Dyspnoea—Etoposide—uterine cancer	0.000513	0.00183	CcSEcCtD
Ticagrelor—ABCB1—female gonad—uterine cancer	0.000508	0.016	CbGeAlD
Ticagrelor—Vomiting—Dactinomycin—uterine cancer	0.000506	0.00181	CcSEcCtD
Ticagrelor—ABCB1—vagina—uterine cancer	0.000505	0.0159	CbGeAlD
Ticagrelor—Rash—Dactinomycin—uterine cancer	0.000502	0.00179	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Etoposide—uterine cancer	0.000497	0.00178	CcSEcCtD
Ticagrelor—Fatigue—Etoposide—uterine cancer	0.000496	0.00177	CcSEcCtD
Ticagrelor—Constipation—Etoposide—uterine cancer	0.000492	0.00176	CcSEcCtD
Ticagrelor—Haematuria—Epirubicin—uterine cancer	0.000482	0.00172	CcSEcCtD
Ticagrelor—Epistaxis—Epirubicin—uterine cancer	0.000477	0.00171	CcSEcCtD
Ticagrelor—Feeling abnormal—Etoposide—uterine cancer	0.000474	0.0017	CcSEcCtD
Ticagrelor—Nausea—Dactinomycin—uterine cancer	0.000472	0.00169	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Etoposide—uterine cancer	0.000471	0.00168	CcSEcCtD
Ticagrelor—Bradycardia—Epirubicin—uterine cancer	0.000462	0.00165	CcSEcCtD
Ticagrelor—Haemoglobin—Epirubicin—uterine cancer	0.000457	0.00163	CcSEcCtD
Ticagrelor—Body temperature increased—Etoposide—uterine cancer	0.000455	0.00163	CcSEcCtD
Ticagrelor—Abdominal pain—Etoposide—uterine cancer	0.000455	0.00163	CcSEcCtD
Ticagrelor—Haemorrhage—Epirubicin—uterine cancer	0.000454	0.00162	CcSEcCtD
Ticagrelor—Urinary tract disorder—Epirubicin—uterine cancer	0.000449	0.0016	CcSEcCtD
Ticagrelor—Oedema peripheral—Epirubicin—uterine cancer	0.000447	0.0016	CcSEcCtD
Ticagrelor—Haematuria—Doxorubicin—uterine cancer	0.000446	0.0016	CcSEcCtD
Ticagrelor—Connective tissue disorder—Epirubicin—uterine cancer	0.000446	0.00159	CcSEcCtD
Ticagrelor—Urethral disorder—Epirubicin—uterine cancer	0.000445	0.00159	CcSEcCtD
Ticagrelor—Epistaxis—Doxorubicin—uterine cancer	0.000442	0.00158	CcSEcCtD
Ticagrelor—Bradycardia—Doxorubicin—uterine cancer	0.000428	0.00153	CcSEcCtD
Ticagrelor—Eye disorder—Epirubicin—uterine cancer	0.000424	0.00152	CcSEcCtD
Ticagrelor—Hypersensitivity—Etoposide—uterine cancer	0.000424	0.00152	CcSEcCtD
Ticagrelor—Haemoglobin—Doxorubicin—uterine cancer	0.000422	0.00151	CcSEcCtD
Ticagrelor—Cardiac disorder—Epirubicin—uterine cancer	0.000422	0.00151	CcSEcCtD
Ticagrelor—Haemorrhage—Doxorubicin—uterine cancer	0.00042	0.0015	CcSEcCtD
Ticagrelor—Urinary tract disorder—Doxorubicin—uterine cancer	0.000415	0.00148	CcSEcCtD
Ticagrelor—Oedema peripheral—Doxorubicin—uterine cancer	0.000414	0.00148	CcSEcCtD
Ticagrelor—Asthenia—Etoposide—uterine cancer	0.000413	0.00148	CcSEcCtD
Ticagrelor—Connective tissue disorder—Doxorubicin—uterine cancer	0.000413	0.00148	CcSEcCtD
Ticagrelor—Angiopathy—Epirubicin—uterine cancer	0.000412	0.00147	CcSEcCtD
Ticagrelor—Urethral disorder—Doxorubicin—uterine cancer	0.000412	0.00147	CcSEcCtD
Ticagrelor—Immune system disorder—Epirubicin—uterine cancer	0.00041	0.00147	CcSEcCtD
Ticagrelor—Mediastinal disorder—Epirubicin—uterine cancer	0.000409	0.00146	CcSEcCtD
Ticagrelor—Pruritus—Etoposide—uterine cancer	0.000407	0.00146	CcSEcCtD
Ticagrelor—Mental disorder—Epirubicin—uterine cancer	0.000398	0.00142	CcSEcCtD
Ticagrelor—Malnutrition—Epirubicin—uterine cancer	0.000395	0.00141	CcSEcCtD
Ticagrelor—Diarrhoea—Etoposide—uterine cancer	0.000394	0.00141	CcSEcCtD
Ticagrelor—Eye disorder—Doxorubicin—uterine cancer	0.000393	0.0014	CcSEcCtD
Ticagrelor—Cardiac disorder—Doxorubicin—uterine cancer	0.00039	0.00139	CcSEcCtD
Ticagrelor—Back pain—Epirubicin—uterine cancer	0.000382	0.00137	CcSEcCtD
Ticagrelor—Angiopathy—Doxorubicin—uterine cancer	0.000381	0.00136	CcSEcCtD
Ticagrelor—Dizziness—Etoposide—uterine cancer	0.000381	0.00136	CcSEcCtD
Ticagrelor—Immune system disorder—Doxorubicin—uterine cancer	0.00038	0.00136	CcSEcCtD
Ticagrelor—Mediastinal disorder—Doxorubicin—uterine cancer	0.000379	0.00135	CcSEcCtD
Ticagrelor—Mental disorder—Doxorubicin—uterine cancer	0.000368	0.00132	CcSEcCtD
Ticagrelor—Vomiting—Etoposide—uterine cancer	0.000366	0.00131	CcSEcCtD
Ticagrelor—Malnutrition—Doxorubicin—uterine cancer	0.000366	0.00131	CcSEcCtD
Ticagrelor—Rash—Etoposide—uterine cancer	0.000363	0.0013	CcSEcCtD
Ticagrelor—Dermatitis—Etoposide—uterine cancer	0.000363	0.0013	CcSEcCtD
Ticagrelor—Headache—Etoposide—uterine cancer	0.000361	0.00129	CcSEcCtD
Ticagrelor—Vertigo—Epirubicin—uterine cancer	0.000355	0.00127	CcSEcCtD
Ticagrelor—Syncope—Epirubicin—uterine cancer	0.000355	0.00127	CcSEcCtD
Ticagrelor—Back pain—Doxorubicin—uterine cancer	0.000354	0.00126	CcSEcCtD
Ticagrelor—Loss of consciousness—Epirubicin—uterine cancer	0.000348	0.00124	CcSEcCtD
Ticagrelor—Cough—Epirubicin—uterine cancer	0.000345	0.00123	CcSEcCtD
Ticagrelor—Nausea—Etoposide—uterine cancer	0.000342	0.00122	CcSEcCtD
Ticagrelor—Hypertension—Epirubicin—uterine cancer	0.000341	0.00122	CcSEcCtD
Ticagrelor—Chest pain—Epirubicin—uterine cancer	0.000337	0.0012	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000334	0.00119	CcSEcCtD
Ticagrelor—Vertigo—Doxorubicin—uterine cancer	0.000329	0.00117	CcSEcCtD
Ticagrelor—Syncope—Doxorubicin—uterine cancer	0.000328	0.00117	CcSEcCtD
Ticagrelor—ABCB1—lymph node—uterine cancer	0.000326	0.0103	CbGeAlD
Ticagrelor—Confusional state—Epirubicin—uterine cancer	0.000325	0.00116	CcSEcCtD
Ticagrelor—Loss of consciousness—Doxorubicin—uterine cancer	0.000322	0.00115	CcSEcCtD
Ticagrelor—Cough—Doxorubicin—uterine cancer	0.000319	0.00114	CcSEcCtD
Ticagrelor—Shock—Epirubicin—uterine cancer	0.000317	0.00113	CcSEcCtD
Ticagrelor—Nervous system disorder—Epirubicin—uterine cancer	0.000316	0.00113	CcSEcCtD
Ticagrelor—Hypertension—Doxorubicin—uterine cancer	0.000316	0.00113	CcSEcCtD
Ticagrelor—Skin disorder—Epirubicin—uterine cancer	0.000313	0.00112	CcSEcCtD
Ticagrelor—Chest pain—Doxorubicin—uterine cancer	0.000311	0.00111	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000309	0.00111	CcSEcCtD
Ticagrelor—Hypotension—Epirubicin—uterine cancer	0.000302	0.00108	CcSEcCtD
Ticagrelor—Confusional state—Doxorubicin—uterine cancer	0.000301	0.00108	CcSEcCtD
Ticagrelor—Shock—Doxorubicin—uterine cancer	0.000294	0.00105	CcSEcCtD
Ticagrelor—Nervous system disorder—Doxorubicin—uterine cancer	0.000293	0.00105	CcSEcCtD
Ticagrelor—Skin disorder—Doxorubicin—uterine cancer	0.00029	0.00104	CcSEcCtD
Ticagrelor—Paraesthesia—Epirubicin—uterine cancer	0.00029	0.00104	CcSEcCtD
Ticagrelor—Dyspnoea—Epirubicin—uterine cancer	0.000288	0.00103	CcSEcCtD
Ticagrelor—Dyspepsia—Epirubicin—uterine cancer	0.000284	0.00102	CcSEcCtD
Ticagrelor—Hypotension—Doxorubicin—uterine cancer	0.000279	0.000997	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000279	0.000996	CcSEcCtD
Ticagrelor—Fatigue—Epirubicin—uterine cancer	0.000278	0.000994	CcSEcCtD
Ticagrelor—Constipation—Epirubicin—uterine cancer	0.000276	0.000986	CcSEcCtD
Ticagrelor—Paraesthesia—Doxorubicin—uterine cancer	0.000268	0.000958	CcSEcCtD
Ticagrelor—Dyspnoea—Doxorubicin—uterine cancer	0.000266	0.000951	CcSEcCtD
Ticagrelor—Feeling abnormal—Epirubicin—uterine cancer	0.000266	0.00095	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Epirubicin—uterine cancer	0.000264	0.000943	CcSEcCtD
Ticagrelor—Dyspepsia—Doxorubicin—uterine cancer	0.000263	0.000939	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000258	0.000921	CcSEcCtD
Ticagrelor—Fatigue—Doxorubicin—uterine cancer	0.000257	0.00092	CcSEcCtD
Ticagrelor—Constipation—Doxorubicin—uterine cancer	0.000255	0.000912	CcSEcCtD
Ticagrelor—Body temperature increased—Epirubicin—uterine cancer	0.000255	0.000912	CcSEcCtD
Ticagrelor—Abdominal pain—Epirubicin—uterine cancer	0.000255	0.000912	CcSEcCtD
Ticagrelor—Feeling abnormal—Doxorubicin—uterine cancer	0.000246	0.000879	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000244	0.000872	CcSEcCtD
Ticagrelor—Hypersensitivity—Epirubicin—uterine cancer	0.000238	0.00085	CcSEcCtD
Ticagrelor—Abdominal pain—Doxorubicin—uterine cancer	0.000236	0.000843	CcSEcCtD
Ticagrelor—Body temperature increased—Doxorubicin—uterine cancer	0.000236	0.000843	CcSEcCtD
Ticagrelor—Asthenia—Epirubicin—uterine cancer	0.000232	0.000827	CcSEcCtD
Ticagrelor—Pruritus—Epirubicin—uterine cancer	0.000228	0.000816	CcSEcCtD
Ticagrelor—Diarrhoea—Epirubicin—uterine cancer	0.000221	0.000789	CcSEcCtD
Ticagrelor—Hypersensitivity—Doxorubicin—uterine cancer	0.00022	0.000786	CcSEcCtD
Ticagrelor—Asthenia—Doxorubicin—uterine cancer	0.000214	0.000766	CcSEcCtD
Ticagrelor—Dizziness—Epirubicin—uterine cancer	0.000213	0.000763	CcSEcCtD
Ticagrelor—Pruritus—Doxorubicin—uterine cancer	0.000211	0.000755	CcSEcCtD
Ticagrelor—Vomiting—Epirubicin—uterine cancer	0.000205	0.000733	CcSEcCtD
Ticagrelor—Diarrhoea—Doxorubicin—uterine cancer	0.000204	0.00073	CcSEcCtD
Ticagrelor—Rash—Epirubicin—uterine cancer	0.000203	0.000727	CcSEcCtD
Ticagrelor—Dermatitis—Epirubicin—uterine cancer	0.000203	0.000726	CcSEcCtD
Ticagrelor—Headache—Epirubicin—uterine cancer	0.000202	0.000722	CcSEcCtD
Ticagrelor—Dizziness—Doxorubicin—uterine cancer	0.000197	0.000706	CcSEcCtD
Ticagrelor—Nausea—Epirubicin—uterine cancer	0.000192	0.000685	CcSEcCtD
Ticagrelor—Vomiting—Doxorubicin—uterine cancer	0.00019	0.000678	CcSEcCtD
Ticagrelor—Rash—Doxorubicin—uterine cancer	0.000188	0.000673	CcSEcCtD
Ticagrelor—Dermatitis—Doxorubicin—uterine cancer	0.000188	0.000672	CcSEcCtD
Ticagrelor—Headache—Doxorubicin—uterine cancer	0.000187	0.000668	CcSEcCtD
Ticagrelor—Nausea—Doxorubicin—uterine cancer	0.000177	0.000634	CcSEcCtD
